Komori
Other Disclosures4549EIKEN CHEMICAL CO.,LTD.Pharmaceuticals

Notice of the Release of "Eiken Chemical × Unko Drill: Stool Testing—Colorectal Cancer Edition"

Eiken Chemical Co., Ltd. jointly produced an educational booklet with 株式会社文響社 to help elementary school students learn about the importance of colorectal cancer screening, and released it on 31 March 2026. The booklet is scheduled to be distributed at elementary schools and educational events nationwide.

Worth reading
54Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Announced details

“Eiken Chemical × Unko Drill: Stool Testing, Colorectal Cancer Edition”“Information for the General Public” page for parents
Applicable field (uses covered by this announcement)

Colorectal cancer screening awareness, health education on fecal occult blood testing, and learning for elementary school students

Launch dateReleased on 31 March 2026 (actual)
Relationship between the counterparty and the company
EIKEN CHEMICAL CO.,LTD.4549
Relationship with the Company

Joint production of the educational booklet. Capital and personnel relationships: not disclosed.

Counterparty株式会社文響社

Head office: Minato-ku, Tokyo; Representative Director and President: Yamamoto Shuji (山本 周嗣). Other attributes: not disclosed.

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services Covered“Eiken Chemical × Unko Drill: Stool Testing, Colorectal Cancer Edition”, “Information for the General Public” page for parents
Counterparty株式会社文響社
Counterparty overviewHead office: Minato-ku, Tokyo; Representative Director and President: Yamamoto Shuji (山本 周嗣). Other attributes: not disclosed.
Relationship with the CompanyJoint production of the educational booklet. Capital and personnel relationships: not disclosed.
Launch dateReleased on 31 March 2026 (actual)
Applicable areaColorectal cancer screening awareness, health education on fecal occult blood testing, and learning for elementary school students
Items this document does not state (12)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The initiative was undertaken to communicate the importance of screening, which is essential for the early detection of colorectal cancer, to the next generation in an easy-to-understand way, and to encourage children’s learning to lead to screening through conversations at home. It was implemented as part of efforts to address a social issue.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of the Release of "Eiken Chemical × Unko Drill: Stool Testing—Colorectal Cancer Edition" | EIKEN CHEMICAL CO.,LTD. (4549) timely disclosure | Komori